ICU admission for solid cancer patients treated with immune checkpoint inhibitors

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline

Julie R. Brahmer, Christina Lacchetti, Bryan J. Schneider et al. · Journal of Clinical Oncology · 2018 · 3.6K citations · Full text

Immunohematology, Cancer Immunosurveillance, Autoimmune Disease +15

Fulminant Myocarditis with Combination Immune Checkpoint Blockade

Douglas B. Johnson, Justin M. Balko, Margaret Compton et al. · New England Journal of Medicine · 2016 · 2.2K citations · Full text

Fatal Myocarditis, Cancer Immunosurveillance, Skeletal Muscle +12

Multisystem Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors for Treatment of Non–Small Cell Lung Cancer

Bairavi Shankar, Jiajia Zhang, Abdul Rafeh Naqash et al. · JAMA Oncology · 2020 · 472 citations · Full text

Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes

Aanika Balaji, Melinda Laine Hsu, Cheng Ting Lin et al. · Journal for ImmunoTherapy of Cancer · 2021 · 103 citations · Full text

Immune-related adverse events: a retrospective look into the future of oncology in the intensive care unit

Adrien Joseph, Audrey Simonaggio, Annabelle Stoclin et al. · Annals of Intensive Care · 2020 · 39 citations · Full text